Proton Spectroscopy in Alzheimer’s Disease and Cognitive Impairment No Dementia: A Community-Based Study
Authors:
- Dionísio AzevedoDADionísio Azevedo
- Mariana TatschMTMariana Tatsch
- Sergio R. HototianSHSergio R. Hototian
- Mario C. BazzarellaMBMario C. Bazzarella
- Cláudio C. CastroCCCláudio C. Castro
- Cássio M.C. BottinoCBCássio M.C. Bottino
- 28 April 2008
- journal article
- clinical trial
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 25 (6) , 491-500
Abstract
Objective: To describe the findings of proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer’s disease (AD) and cognitive impairment, no dementia (CIND) elderly from a community-based sample. Methods: Thirteen patients with AD, 12 with CIND and 15 normal individuals were evaluated. The 1H-MRS was performed in the right temporal, left parietal and medial occipital regions studying the metabolites N-acetylaspartate (NAA), creatine (Cr), choline (Cho) and myoinositol (mI). The clinical diagnosis was based on standardized cognitive tests – MMSE and CAMDEX – and the results correlated with the 1H-MRS. Results: Parietal Cho was higher in control individuals and lower in CIND subjects. AD and control groups were better identified by temporal and parietal mI combined with the temporal NAA/Cr ratio. CIND was better identified by parietal Cho. Conclusion: The 1H-MRS findings confirmed the hypothesis that metabolic alterations are present since the first symptoms of cognitively impaired elderly subjects. These results suggest that combining MRS from different cerebral regions can help in the diagnosis and follow-up of community elderly individuals with memory complaints and AD.Keywords
This publication has 36 references indexed in Scilit:
- Prevalence of Cognitive and Functional Impairment in a Community Sample from São Paulo, BrazilDementia and Geriatric Cognitive Disorders, 2007
- Instrumentos combinados na avaliação de demência em idosos: resultados preliminaresArquivos de Neuro-Psiquiatria, 2003
- Doença de Alzheimer e espectroscopia por ressonância magnética do hipocampoArquivos de Neuro-Psiquiatria, 2001
- Glutamate uptake is decreased in platelets from Alzheimer's disease patientsAnnals of Neurology, 2000
- Amyloid β-peptide inhibits Na+-dependent glutamate uptakeLife Sciences, 1999
- 1 H‐MRS, MRI‐Based Hippocampal Volumetry, and 99m Tc‐HMPAO‐SPECT in Normal Aging, Age‐Associated Memory Impairment, and Probable Alzheimer's DiseaseJournal of the American Geriatrics Society, 1996
- The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some normsPsychological Medicine, 1989
- CAMDEX: A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of DementiaThe British Journal of Psychiatry, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- “Mini-mental state”Journal of Psychiatric Research, 1975